CBD food decision made by Food Standards Agency

By Rod Addy contact

- Last updated on GMT

After 31 March 2021, only CBD-containing products that have submitted a valid application will be allowed to stay on the market
After 31 March 2021, only CBD-containing products that have submitted a valid application will be allowed to stay on the market

Related tags: Food safety

The Food Standards Agency (FSA) is giving the CBD industry a deadline of 31 March 2021 to submit valid novel food authorisation applications.

After 31 March next year, only products which have submitted a valid application will be allowed to remain on the market.

Local authorities have been advised that businesses should be able to sell their existing CBD  products during this time, provided they are not incorrectly labelled, are not unsafe to eat and do not contain substances that fall under drugs legislation. 

In addition, the FSA is today advising those who are pregnant, breastfeeding or taking any medication not to consume CBD products. Healthy adults are also advised to think carefully before taking CBD, and the FSA recommends no more than 70mg a day (about 28 drops of 5% CBD) unless under medical direction.

This new precautionary advice is based on recent findings by the government’s Committee on Toxicity (COT).

CBD products widely available 

CBD products are widely available on the high street, but are not properly authorised,” ​said Emily Miles, chief executive of the FSA.

The CBD industry must provide more information about the safety and contents of these products to the regulator before 31 March 2021, or the products will be taken off the shelves.

”The actions that we’re taking today are a pragmatic and proportionate step in balancing the protection of public health with consumer choice. It’s now up to industry to supply this information so that the public can be reassured that CBD is safe and what it says it is.

Potential adverse health effects 

Professor Alan Boobis, chairman of the Committee on Toxicity, said: ”My committee has reviewed the evidence on CBD food products and found evidence there are potential adverse health effects from the consumption of these products. We are particularly concerned about pregnant or breast-feeding women and people on medication. 

”We don’t know enough to be sure about such a risk, but I am pleased with the sensible and pragmatic approach the FSA is taking. The committee will continue to keep these products under review in the months ahead.

Related topics: Food safety and labelling, Legal

Related news

Show more

Related products

Modern ERP system enables food waste reduction

Modern ERP system enables food waste reduction

Epicor | 05-Sep-2019 | Technical / White Paper

We’re all becoming increasingly aware and mindful of wastage in our personal lives. Food waste is already a significant concern for the food and beverage...

Emerging Risks: Preparedness in Food Manufacturing

Emerging Risks: Preparedness in Food Manufacturing

Risk and Resilience | 04-Sep-2017 | Technical / White Paper

This paper argues the need for organisations and value chains in the Food Manufacturing Sector to reconsider how they view risk management and resilience...

Follow us

Featured Events

View more

Products

View more

Webinars